Latest Blogs

Jul 27, 2022
Dr. Anna M Laucis discusses the landscape and future opportunities for narrative medicine, along with her own explorations in original artwork and poetry.
Jul 20, 2022
"The weeks following the ASCO Annual Meeting always feel like a bit of a reset, as we emerge... energized from connecting with friends and colleagues."
Jul 19, 2022
 Cancer changes the relationship between what we think is certain and the fallibility of our assumptions; it can also be a source of discovery about ourselves and our relationships.
Jul 12, 2022
"If you are young researcher in an LMIC trying to launch your own career, I highly recommend building collaborations and networks with oncologists around the globe," said Dr. Khalid El Bairi.
Subscribe to this column

Nagi S. El Saghir, MD, FASCO, FACP

Nagi S. El Saghir, MD, FACP, FASCO, is a professor and head of the Hematology/Oncology Division at the American University of Beirut, and director of the Breast Center of Excellence at the Naef K. Basile Cancer Institute at the American University of Beirut Medical Center, in Beirut, Lebanon. He is the founding president of the Lebanese Society of Medical Oncology (LSMO), the Lebanese Breast Cancer Foundation (LBCF), and Best of ASCO Lebanon. He has served on several committees within the European Society for Medical Oncology (ESMO) and co-authored International Consensus Guidelines for Advanced Breast Cancer (ABC Guidelines) and Breast Health Global Initiative (BHGI) Guidelines. An ASCO member since 1984, Dr. El Saghir is a member of the Journal of Global Oncology editorial board, past chair of the ASCO International Affairs Committee, and co-chair of the Clinical Practice Guidelines Committee's Guidelines Advisory Group for Resource Stratification, as well as a past member of Global Oncology Leadership Task Force and Global Curriculum Committee, among other volunteer roles. Follow Dr. El Saghir on Twitter @NagiSaghir.

Disclosure.

Mar 01, 2016
Reflecting on the challenges of delivering cancer care in regions rocked by hostilities, but seeing hope in impactful educational and scientific meetings such as the recent Beirut Breast Cancer Conference (BBCC-4).

Pages